management of abnormal lower uterine segment after fetal delivery in cesarean sectio
Recruiting
- Conditions
- Postpartum hemorrhageplacenta accretaplacenta previaReproductive Health and Childbirth - Fetal medicine and complications of pregnancy
- Registration Number
- ACTRN12616001660471
- Lead Sponsor
- shatby maternity university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Participants will be included if they have one of the following:
1. ballooned and oozing lower uterine segment from placenta previa
2. placenta accreta
3. thinned out lower segment
Exclusion Criteria
1.placenta percreta
2.hemodynamically unstable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Control of hemorrhage from lower uterine segment by reviewing the medical records[During surgery]
- Secondary Outcome Measures
Name Time Method Duration of surgery by review of medical records[During surgery]
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does inclusion of both uterine arteries in plication sutures (ACTRN12616001660471) affect hemostasis in placenta previa and accreta?
What comparative effectiveness data exist for multiple plication sutures versus standard uterine artery ligation in postpartum hemorrhage prevention?
Which biomarkers correlate with uterine segment thinning and placenta accreta severity to guide plication suture use in ACTRN12616001660471?
What adverse event profiles are associated with multiple plication sutures in abnormal uterine segments, and how are they mitigated?
Are hemostatic agents like tranexamic acid or uterotonics synergistic with plication suture techniques in managing placenta previa-related hemorrhage?